12‑weeks fisetin supplementation and interval resistance with aerobic training: changes in Maresin‑1 and inflammatory markers in men with obesity: a randomized controlled trial
Mehran Alipour, Ayoub Saeidi, Keyvan Hejazi, Ismail Laher, Hassane Zouhal · 2026
Read 12‑weeks fisetin supplementation and interval resistance with aerobic training: changes in Maresin‑1 and inflammatory markers in men with obesity: a randomized controlled trial by Mehran Alipour, Ayoub Saeidi, Keyvan Hejazi, Ismail Laher, Hassane Zouhal (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13224698.txt.
Description
Mehran Alipour and co-authors conduct a 2026 randomised trial in men with obesity, pairing a plant compound called fisetin with a mixed exercise programme. Obesity involves low-grade inflammation, and a molecule named Maresin-1 helps switch inflammation off, though human intervention data are scarce. Forty-four men spent twelve weeks in one of four arms: supplement alone, training alone, both, or neither.
Training combined resistance intervals with progressive aerobic work, while the supplement dose was 200 milligrams daily. Maresin-1 rose in both training groups, and inflammatory markers fell across the active arms. Blood sugar, insulin, and insulin resistance also improved everywhere except in controls, with the largest gains where training and fisetin were combined.
Catalog record
| CREATOR | Mehran Alipour, Ayoub Saeidi, Keyvan Hejazi, Ismail Laher, Hassane Zouhal |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |